New genetic test predicts who benefits from hep C drugs: study
Monday, December 22, 2008 - 18:28
in Health & Medicine
An analysis of genetic patterns in the hepatitis C virus may help predict which patients are likely to respond to treatment, researchers have found. About half of patients infected with the virus do not respond to the costly therapy that has "terrible" side-effects, study author says.
Read the whole article on CBC: Health
More from CBC: Health
Related
- How to tell if a hepatitis-C-virus-infected patient will respond to therapyMon, 22 Dec 2008, 17:44:02 EST
- Using math to understand hep. C: Patterns paint picture of who will respond to treatmentMon, 22 Dec 2008, 17:43:52 EST
- Predicting patient response to gleevec in gastrointestinal stromal tumorsTue, 21 Apr 2009, 15:16:03 EDT
- Drug cocktail offers new hope for hepatitis C patientsWed, 30 Mar 2011, 18:04:10 EDT
- Gene signature may predict patient response to therapy for gastrointestinal stromal tumorsThu, 14 May 2009, 18:51:36 EDT